Proxecto de investigación
Comparative study between an oral formulation of the phytocannabinoid derivative VCE-003.2 (EHP-102) and L-DOPA/Benserazide in Parkinson’s disease using 6-hydroxydopamine-lesioned mice
date_range
Duración do 01 de xaneiro de 2022 ao 31 de decembro de 2022
(12 meses)
Investigadores/as
JOSÉ JAVIER
FERNÁNDEZ RUIZ
Responsable
MARÍA CONCEPCIÓN
GARCÍA GARCÍA
Responsable